The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Schlossberg Mark A since 2013.
This trader's CIK number is 1520533.
At the time of last reporting, Schlossberg Mark A was the SVP - Legal & General Counsel of Cytokinetics Inc. (stock ticker symbol CYTK).
Also see all insider trading activities at Cytokinetics Inc.
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2022 | CYTK | 0 | $0 | 25,196 | $855,731 | 60,817 | $726,337 |
2021 | CYTK | 0 | $0 | 19,979 | $713,969 | 19,979 | $140,452 |
2020 | CYTK | 0 | $0 | 20,000 | $480,730 | 20,000 | $140,600 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2015 | IPXL | 0 | $0 | 12,106 | $524,701 | 0 | $0 |
2013 | IPXL | 1,000 | $16,728 | 0 | $0 | 0 | $0 |
2. Impax Laboratories Inc (IPXL)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2022-03-15 | CYTK | Sale | 25,196 | 33.96 | 855,731 |
2022-03-15 | CYTK | Option Ex | 60,817 | 11.94 | 726,337 |
2021-10-19 | CYTK | Option Ex | 19,979 | 7.03 | 140,452 |
2021-10-19 | CYTK | Sale | 19,979 | 35.74 | 713,969 |
2020-08-21 | CYTK | Option Ex | 10,000 | 7.03 | 70,300 |
2020-08-21 | CYTK | Sale | 10,000 | 25.00 | 250,000 |
2020-07-29 | CYTK | Option Ex | 10,000 | 7.03 | 70,300 |
2020-07-29 | CYTK | Sale | 10,000 | 23.07 | 230,730 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2015-09-11 | IPXL | Sale | 7,457 | 43.30 | 322,888 |
2015-08-27 | IPXL | Sale | 4,649 | 43.41 | 201,813 |
2013-03-12 | IPXL | Buy | 1,000 | 16.73 | 16,728 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Schlossberg Mark A (SVP - Legal & General Counsel of Cytokinetics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.